Geneos Wealth Management’s AXS Cannabis ETF THCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-23
Closed 2681
2022
Q2
$0 Hold
23
﹤0.01% 2833
2022
Q1
$1K Hold
23
﹤0.01% 2723
2021
Q4
$1K Sell
23
-5
-18% -$549 ﹤0.01% 2741
2021
Q3
$3K Hold
28
﹤0.01% 2613
2021
Q2
$4K Sell
28
-369
-93% -$64.6K ﹤0.01% 2542
2021
Q1
$72K Buy
397
+9
+2% +$1.76K ﹤0.01% 1442
2020
Q4
$5K Buy
+388
New +$43K ﹤0.01% 2511

Other funds holding THCX

Geneos Wealth Management's THCX Position: Q3 2022 in Review

Geneos Wealth Management sold out of AXS Cannabis ETF (THCX) in Q3 2022, closing a stake of 23 shares.

Geneos Wealth Management first reported a position in THCX in Q4 2020 and held it in 7 quarters. The position peaked at $72K in Q1 2021. 37 funds tracked by Wall St. Rank hold THCX as of Q3 2022.

  • Geneos Wealth Management reported no remaining AXS Cannabis ETF position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 23 AXS Cannabis ETF shares in Q3 2022.
  • Geneos Wealth Management first reported a position in AXS Cannabis ETF in Q4 2020 and held it in 7 quarters.
  • Geneos Wealth Management's AXS Cannabis ETF position peaked at $72K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held AXS Cannabis ETF as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.